The prognostic importance of follow-up haemodynamics and the validity of multidimensional risk assessment are not well established for systemic sclerosis (SSc)-associated pulmonary arterial hypertension (PAH). We assessed incident SSc-PAH patients to determine the association between clinical and haemodynamic variables at baseline and first follow-up right heart catheterisation (RHC) with transplant-free survival. RHC variables included cardiac index, stroke volume index (SVI), pulmonary arterial compliance and pulmonary vascular resistance. Risk assessment was performed according to the number of low-risk criteria: functional class I or II, 6-min walking distance (6MWD) >440 m, right atrial pressure <8 mmHg and cardiac index ≥2.5 L·min −1 ...
Pulmonary arterial hypertension (PAH) is a leading cause of morbidity and mortality in patients with...
Pulmonary arterial hypertension (PAH) is a pro-gressively fatal disorder that affects patients inde-...
Pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) has been poo...
Background: In this study, we investigated the impact of the new haemodynamic definition of pulmonar...
BACKGROUND: In this study, we investigated the impact of the new haemodynamic definition of pulmonar...
The aim of the present study was to investigate the prognostic value of exercise haemodynamics measu...
Objectives: To describe the survival rate in a cohort of systemic sclerosis (SSc) patients with pulm...
The objective of this study was to evaluate the incidence of pulmonary hypertension (PH) and determi...
BACKGROUND: Pulmonary arterial hypertension (PAH) is a major cause of morbidity and mortality in pat...
To assess severity markers and outcomes of patients with systemic sclerosis (SSc) with or without pu...
BACKGROUND: Pulmonary arterial hypertension (PAH) is a leading cause of mortality in systemic sclero...
OBJECTIVE: Pulmonary arterial hypertension (PAH) is a severe complication of systemic sclerosis (SSc...
Systemic sclerosis-associated pulmonary hypertension (SSc-PH) and pulmonary arterial (PA) hypertensi...
Pulmonary arterial hypertension (PAH) is a common complication of systemic sclerosis (SSc) with high...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/106105/1/acr22121.pd
Pulmonary arterial hypertension (PAH) is a leading cause of morbidity and mortality in patients with...
Pulmonary arterial hypertension (PAH) is a pro-gressively fatal disorder that affects patients inde-...
Pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) has been poo...
Background: In this study, we investigated the impact of the new haemodynamic definition of pulmonar...
BACKGROUND: In this study, we investigated the impact of the new haemodynamic definition of pulmonar...
The aim of the present study was to investigate the prognostic value of exercise haemodynamics measu...
Objectives: To describe the survival rate in a cohort of systemic sclerosis (SSc) patients with pulm...
The objective of this study was to evaluate the incidence of pulmonary hypertension (PH) and determi...
BACKGROUND: Pulmonary arterial hypertension (PAH) is a major cause of morbidity and mortality in pat...
To assess severity markers and outcomes of patients with systemic sclerosis (SSc) with or without pu...
BACKGROUND: Pulmonary arterial hypertension (PAH) is a leading cause of mortality in systemic sclero...
OBJECTIVE: Pulmonary arterial hypertension (PAH) is a severe complication of systemic sclerosis (SSc...
Systemic sclerosis-associated pulmonary hypertension (SSc-PH) and pulmonary arterial (PA) hypertensi...
Pulmonary arterial hypertension (PAH) is a common complication of systemic sclerosis (SSc) with high...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/106105/1/acr22121.pd
Pulmonary arterial hypertension (PAH) is a leading cause of morbidity and mortality in patients with...
Pulmonary arterial hypertension (PAH) is a pro-gressively fatal disorder that affects patients inde-...
Pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) has been poo...